Form4insider filings, from the source

SEC Form 4 · accession 0001209191-18-058348

Intra-Cellular Therapies, Inc. · ITCI

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Nov 9, 2018
Accepted (ET)
Nov 13, 2018 · 5:34 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001567514

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Nov 9, 2018S25,000$18.24D85,742IHeld by the Joel S. Marcus and Barbara A. Marcus Family Trust
Common StockNov 12, 2018S7,000$17.94D78,742IHeld by the Joel S. Marcus and Barbara A. Marcus Family Trust
Common Stockholding———21,671D
Common StockF2holding———47,425ISee Footnote
Common StockF3holding———1,143,731ISee Footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses